Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Return on Equity: 2012-2025

Historic Return on Equity for Ani Pharmaceuticals (ANIP) over the last 14 years, with Sep 2025 value amounting to 0.09%.

  • Ani Pharmaceuticals' Return on Equity rose 10.00% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 10.00%. This contributed to the annual value of -0.04% for FY2024, which is 8.00% down from last year.
  • According to the latest figures from Q3 2025, Ani Pharmaceuticals' Return on Equity is 0.09%, which was up 459.33% from -0.02% recorded in Q2 2025.
  • In the past 5 years, Ani Pharmaceuticals' Return on Equity ranged from a high of 0.09% in Q3 2025 and a low of -0.17% during Q2 2022.
  • Its 3-year average for Return on Equity is 0.01%, with a median of -0.01% in 2023.
  • As far as peak fluctuations go, Ani Pharmaceuticals' Return on Equity rose by 20bps in 2023, and later declined by 12bps in 2025.
  • Over the past 5 years, Ani Pharmaceuticals' Return on Equity (Quarterly) stood at -0.15% in 2021, then climbed by 3bps to -0.12% in 2022, then increased by 16bps to 0.04% in 2023, then dropped by 8bps to -0.04% in 2024, then increased by 10bps to 0.09% in 2025.
  • Its Return on Equity stands at 0.09% for Q3 2025, versus -0.02% for Q2 2025 and -0.05% for Q1 2025.